Fetal Myocardial Performance Index in Diabetic Pregnancies
- Conditions
- Gestational DiabetesMyocardial Dysfunction
- Interventions
- Other: myocardial performance index
- Registration Number
- NCT03925064
- Brief Summary
The myocardial tissue is the most likely structure affected by hyperglycemia. The myocardial performance index (MPI) is a pulsed wave Doppler-derived index of global myocardial function. It is defined as the sum of the isovolumetric contraction time (ICT) and isovolumetric relaxation time (IRT) divided by the ejection time (ET) The fetal right heart contributes more to the cardiac output than the left heart; therefore, it is important to assess the right ventricular function. The investigators will measure right ventricular MPI in diabetic and normal pregnancies.
- Detailed Description
Gestational diabetes mellitus (GDM) is the most common metabolic disorder in pregnancy, with an overall prevalence of 3-7 % during pregnancy. The myocardial tissue is the most likely structure affected by hyperglycemia. The myocardial performance index (MPI) is a pulsed wave Doppler-derived index of global myocardial function. It is defined as the sum of the isovolumetric contraction time (ICT) and isovolumetric relaxation time (IRT) divided by the ejection time (ET) The fetal right heart contributes more to the cardiac output than the left heart; therefore, it is important to assess the right ventricular function. The investigators will measure right ventricular MPI in diabetic and normal pregnancies.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 130
- 18-40 years old pregnant women
- fetal cardiac anomalies
- multiple gestations
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Diabetic pregnancies myocardial performance index Pregnant women with pregestational or gestational diabetes mellitus non-diabetic pregnancies myocardial performance index Pregnant women without pregestational or gestational diabetes mellitus
- Primary Outcome Measures
Name Time Method ultrasonographic myocardial performance index values during procedure cardiac contractility will be measured with Doppler ultrasonography
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kanuni SSRTH
🇹🇷Istanbul, Turkey